Jaime Bartushak
2019
In 2019, Jaime Bartushak earned a total compensation of $525.5K as Chief Financial Officer at Citius Pharmaceuticals, a 14% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $105,560 |
---|---|
Option Awards | $129,969 |
Salary | $290,000 |
Total | $525,529 |
Bartushak received $290K in salary, accounting for 55% of the total pay in 2019.
Bartushak also received $105.6K in non-equity incentive plan and $130K in option awards.
Rankings
In 2019, Jaime Bartushak's compensation ranked 11,623rd out of 13,971 executives tracked by ExecPay. In other words, Bartushak earned more than 16.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,623 | 17th |
Manufacturing | 4,710 | 17th |
Chemicals And Allied Products | 1,857 | 16th |
Drugs | 1,600 | 15th |
Pharmaceutical Preparations | 1,184 | 15th |
Bartushak's colleagues
We found two more compensation records of executives who worked with Jaime Bartushak at Citius Pharmaceuticals in 2019.
News
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018